Weight management beyond GLP-1 A recently published review in the journal Obesity Reviews by Stamford Health found that significant weight is regained after stopping GLP-1 therapy, and the amount regained was proportional to the amount initially lost
10.3390/biomedicines10051168 [DOI] [PMC free article] [PubMed] [Google Scholar] 68.Vianello E, Beltrami AP, Aleksova A, Janjusevic M, Fluca AL, Corsi Romanelli MM, et al
Through dose reminders, weekly progress reports, and an integrated health education library, Pivot helps users stay consistent between clinical touchpoints turning daily actions into measurable, long-term outcomes
(David Paul Morris/Bloomberg / Getty Images) Glucagon-like peptide-1 (GLP-1) is a hormone that impacts glucose and is regulated by GLP-1 receptors